# Safety and Efficacy of Tocotrienols in Post-CABG Atrial Fibrillation

> **NCT03807037** · PHASE2,PHASE3 · COMPLETED · sponsor: **Monash University Malaysia** · enrollment: 250 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DIETARY_SUPPLEMENT:** Tocotrienols
- **DRUG:** Placebo oral capsule

## Key facts

- **NCT ID:** NCT03807037
- **Lead sponsor:** Monash University Malaysia
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-17
- **Primary completion:** 2021-12-30
- **Final completion:** 2021-12-30
- **Target enrollment:** 250 (ACTUAL)
- **Last updated:** 2022-08-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03807037

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03807037, "Safety and Efficacy of Tocotrienols in Post-CABG Atrial Fibrillation". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03807037. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*